eXoZymes (EXOZ) vs Tevogen (TVGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
eXoZymes (EXOZ) has outperformed Tevogen (TVGN) over the past year, losing 59.0% versus a loss of 82.5%. eXoZymes is the larger company by market cap ($51.5 million vs $43.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EXOZ | TVGN |
|---|---|---|
| Share price | $5.54 | $6.68 |
| Market cap | $51.55M | $43.50M |
| 1-day change | 0.00% | +2.93% |
| YTD return | -49.17% | -60.79% |
| 1-year return | -58.96% | -82.51% |
| EPS (TTM) | $-1.19 | $-6.74 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.40 | $39.00 |
| 52-week low | $4.35 | $3.64 |
| Distance from 52-week high | -69.89% | -82.87% |
| Average volume | 6.80K | 9.75K |
| Shares outstanding | 9.30M | 6.51M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EXOZ has outperformed TVGN by 23.5 percentage points over the past year.
EXOZ vs TVGN FAQ
Which is bigger, eXoZymes or Tevogen?
eXoZymes (EXOZ) is larger, with a market capitalization of $51.55M compared with $43.50M for Tevogen (TVGN).
Which stock has performed better over the past year, EXOZ or TVGN?
EXOZ returned -58.96% over the past 12 months, compared with -82.51% for TVGN (price return, excluding dividends). Past performance does not predict future results.
Are eXoZymes and Tevogen in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.